Status:

RECRUITING

Registry of Subjects at Risk of Pancreatic Cancer

Lead Sponsor:

Associazione Italiana per lo Studio del Pancreas

Conditions:

Familial Pancreatic Cancer

BRCA1 Mutation

Eligibility:

All Genders

18-80 years

Brief Summary

IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.

Detailed Description

Pancreatic cancer is a devastating disease with a dismal prognosis. One of the ways to improve survival might be early detection. Within years, many predisposing diseases or genetic conditions have b...

Eligibility Criteria

Inclusion

  • Inclusion Criteria to enter the registry:
  • individuals with at least two relatives suffering from pancreatic cancer, with at least 1 first-degree and until the third-degree
  • subjects with known genetic mutation of BRCA2, BRCA1, p16, PALB2 with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer
  • subjects suffering from FAMMM Syndrome
  • subjects suffering from Peutz-Jeghers Syndrome
  • subjects suffering from PRSS-1- or CFTR- or SPINK-1- related pancreatitis
  • subjects suffering from Lynch syndrome with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer
  • Inclusion criteria to join the "radiologic follow-up":
  • 45 years or 10 years younger than the youngest index case of pancreatic cancer in the family for familial cases
  • 40 years or 5 years younger than the youngest index case of pancreatic cancer for subjects suffering from hereditary/genetic pancreatitis, Lynch syndrome, or carrying a known BRCA 1/2, PALB2, p16 genetic mutation with familiarity for pancreatic cancer
  • 30 years for subjects suffering from FAMMM, Peutz-Jeghers syndrome
  • Exclusion Criteria:
  • \- pregnancy

Exclusion

    Key Trial Info

    Start Date :

    August 20 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 20 2045

    Estimated Enrollment :

    1000 Patients enrolled

    Trial Details

    Trial ID

    NCT04095195

    Start Date

    August 20 2019

    End Date

    September 20 2045

    Last Update

    January 13 2023

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Istituto Clinico Humanitas

    Rozzano, Milan, Italy

    2

    Ospedale Pederzoli

    Peschiera del Garda, Verona, Italy

    3

    San Raffele Vita Salute University Hospital

    Milan, Italy

    4

    Chirurgia Generale e del Pancreas

    Verona, Italy, 37134

    Registry of Subjects at Risk of Pancreatic Cancer | DecenTrialz